This was an observational, descriptive, retrospective, single-center study of cases of nephrectomies for non-functional ...

To avoid positive surgical margins, frozen-section biopsies of the tumor bed have been performed. One study of 301 patients who underwent NSS for tumors with a mean diameter of 3.6 cm analyzed ...

Kidney cancer is among the most lethal of urologic malignancies. The rising incidence of kidney cancer is attributable to greater detection of incidental small renal masses (≤4 cm) from increased use ...

Experts recently developed 23 consensus practice points/statements regarding the use of nephrectomy in autosomal dominant polycystic kidney disease (ADPKD). Regardless of when it was performed in ...

Nephron-sparing surgery may not reduce the risk for later kidney failure in patients with kidney cancer and stage 4 CKD. Despite the promise of nephron-sparing, new study findings suggest that the ...

Kidney cancer is one of the few malignancies in which surgical resection of the primary disease, or cytoreductive nephrectomy, has held tremendous importance. Historically, systemic therapy was ...

Preliminary results from a randomized phase III trial of adjuvant interleukin-2, interferon alpha and 5-fluorouracil in patients with a high risk of relapse after nephrectomy for renal cell carcinoma ...

In patients with clinical stage 1 (cT1) renal masses, many physicians opt for nephron-sparing surgery, such as partial nephrectomy (PN) versus radical nephrectomy (RN). Both procedures have been shown ...

Major complications occur in 7.0% of patients undergoing nephrectomy with a diagnosis of autosomal dominant polycystic kidney ...

A study investigated the safety of nephrectomy after exposure to HIF-2α antagonists for localized VHL-deficient kidney cancer.